Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent
company of Organigram Inc., a leading licensed producer of cannabis, this
morning announced that it has received final approval to list its common shares
on the Toronto Stock Exchange (“TSX”). The company’s common shares will start
trading on the TSX when the market opens on Thursday, August 22, 2019, under
the symbol ‘OGI’. In order to ensure continuous trading for the company’s
shareholders during the uplisting, Organigram’s shares will be delisted from
the TSX Venture Exchange (“TSX.V”) at the beginning of trading on the TSX.
To view the full press release, visit http://ibn.fm/Szbs9
About Organigram Holdings Inc.
Organigram Holdings is a TSX Venture Exchange and NASDAQ
Global Select-listed company whose wholly owned subsidiary, Organigram Inc., is
a licensed producer of cannabis and cannabis-derived products in Canada.
Organigram is focused on producing the highest-quality, indoor-grown cannabis
for patients and adult-recreational consumers in Canada, as well as developing
international business partnerships to extend the company’s global footprint.
Organigram has also developed a portfolio of legal adult-use recreational
cannabis brands including the Edison Cannabis Company, Ankr Organics, Trailer
Park Buds and Trailblazer. Organigram’s primary facility is located in Moncton,
New Brunswick, and the company is regulated by the Cannabis Act and the
Cannabis Regulations (Canada). For more information, visit the company’s
website at www.Investors.Organigram.ca.
NOTE TO INVESTORS: The latest news and updates
relating to OGI are available in the company’s newsroom at http://ibn.fm/OGRMF
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
